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Abstract 20 
The increasing rate of cancer incidence has encouraged the search for novel natural 21 
sources of anticancer compounds. The presence of small quantities of taxol and taxanes 22 
in Corylus avellana L. has impelled new potential applications for this plant in the field 23 
of biomedicine. In the present work, the cell viability-reducing activity of stems and 24 
leaves from three different hazel trees was studied against three human-derived cancer 25 
cell lines (HeLa, HepG2 and MCF-7). Both leaf and stem extracts significantly reduced 26 
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viability of the three cell lines either after maceration with methanol or using taxane 27 
extraction methods. Since maceration reduced cell viability to a greater extent than 28 
taxane extraction methods, we scaled up the maceration extraction process using a 29 
method for solid/liquid extraction (Zippertex technology). Methanol leaf extracts 30 
promoted a higher reduction in viability of all cell lines assayed than stem extracts. 31 
Fractionation of methanol leaf extracts using silica gel chormatography led to the 32 
purification and identification of two compounds by HPLC-MS and NMR: (3R,5R)-3,5-33 
dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-β-D-glucopyranoside and quercetin-34 
3-O-rhamnoside. The isolated compounds decreased viability of HeLa and HepG2 cells 35 
to a greater extent than MCF-7 cells. Our results suggest a potential use of C. avellana 36 
extracts in the pharmacotherapy of cervical cancer and hepatocarcinoma and, to a lesser 37 
extent, breast cancer. 38 
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3-O-β-D-glucopyranoside; DW, dry weight; ESI, Electrospray ionization; EtOH, 46 
ethanol; HeLa, human cervical cancer cells; HepG2, liver hepatocellular cells; HGF, 47 
normal human gingival fibroblast; HL-60, human promyelocytic leukemia cells;  48 
HPLC, high-performance liquid chromatography; HSC-2, oral squamous cell 49 
carcinoma; IC50, half maximal inhibitory concentration; MCF-7, human breast 50 
adenocarcinoma cell line; MeOD, deuterated methanol;  MeOH, methanol; MS, mass 51 
spectrometry; MTT, 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide); 52 
NMR, nuclear magnetic resonance; PPARs, peroxisome proliferator-activated receptors; 53 
QR, quercetin-3-O-rhamnoside; SDS, sodium dodecyl sulfate; SK-Mes-1, human lung 54 
cancer cell line; THF-a, tumor necrosis factor alpha; NF-kb, nuclear factor kappa-B 55 
 56 
1. Introduction 57 
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Drug development has a long background of searching for active natural compounds in 58 
plants, many of which have been used in traditional medicine to treat a wide range of 59 
diseases and infections. Almost half the drugs approved since 1994 are based on natural 60 
products [1]. Concerning drugs used for cancer treatment, more than 60% have a natural 61 
origin and natural products are a major source for drug discovery [2].  62 
The recent increase of cancer incidence has promoted a growing interest in finding new 63 
active compounds to be used to fight the disease. The discovery of taxanes in hazel 64 
plant extracts triggered an interest to study natural products from this plant and its 65 
secondary metabolites [3,4,5,6]. In C. avellana, over 100 compounds have been 66 
described and classified as organic acids, triacylglycerols, phytosterols, tocols, phenolic 67 
acids, diarylheptanoids, flavonoids, tannins, isoflavones, lignans, terpenes and taxanes.  68 
Previous studies reported a taxol-dependent antiproliferative activity in extracts of C. 69 
avellana cell cultures. Treatment of SK-Mes-1 cells (a human cell line derived from 70 
lung cancer) with extracts from C. avellana cell culture medium blocked cancer cells at 71 
the metaphase/anaphase transition more effectively than those treated with yew extract 72 
[3]. Recently, the effect of a C. avellana cell culture extract was evaluated in the MCF-7 73 
cancer cell line (derived from breast cancer). The study confirmed the aforementioned 74 
activity, and suggested that the C. avellana cell culture extracts were more effective 75 
than pure taxol. It was therefore hypothesized that C. avellana extracts may present 76 
compounds that could enhance its effects [7]. Moreover, the antiproliferative activity of 77 
extracts of C. avellana trees has not been previously studied.  78 
In the present study, bioassay-guided experiments were carried out to isolate and 79 
characterize compounds from C. avellana with potential anticancer activity. For this 80 
purpose, compounds from C. avellana leaves and stems were extracted using different 81 
methodologies, and their anticancer activity was evaluated using the 3-(4,5-82 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in three human 83 
cancer cell lines: HeLa (derived from cervical cancer cells), HepG2 (derived from liver 84 
hepatocarcinoma) and MCF-7. 85 
 86 
2. Materials and Methods 87 
2.1 Mammalian cell lines  88 
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HeLa, HepG2 and MCF-7 cell lines were obtained from ATCC (ATCC nos.: CCL-2, 89 
HB-8065 and HTB-22, respectively). The cells were cultured in Dulbecco's Modified 90 
Eagle's (DMEM) medium without pyruvate, supplemented with 100 IU/mL penicillin, 91 
100 µg/mL streptomycin and 10 % (v/v) of heat inactivated fetal bovine serum. All the 92 
components were purchased from Gibco (Invitrogen, Barcelona, Spain). The cells were 93 
grown at 37 ºC in 5 % CO2. 94 
 95 
2.2 Plant material and extractions  96 
Stems and leaves of Corylus avellana L. were collected in October 2014 from three 97 
mature trees in Catalonia: (I) wild type in Barcelona, (II) wild type in Terrassa, and (III) 98 
a cultivar in Tarragona. The plant materials were identified by Dr. Joan Vallès, 99 
Professor of Botany at the Faculty of Pharmacy at the University of Barcelona, and 100 
deposited in the herbarium of the Documentation Centre of Plant Biodiversity 101 
(CeDocBiV), University of Barcelona (voucher specimens: BCN 131396, BCN 131397 102 
and BCN 131398, respectively). Plant material was air-dried overnight at 60 ºC and 103 
powdered.  104 
2.2.1 Screening of extraction procedures  105 
Two different extraction procedures were tested in the screening assays. 1) E-extraction: 106 
Taxane extraction from 1g freeze-dried leaves or stems using methanol:water (9:1,v/v) 107 
[8] and 2) M-extraction: Extraction by maceration from 1 g of freeze-dried leaves or 108 
stems in methanol (MeOH) 90%:H2O 10% (40 mL, 24 h). All the extraction fractions 109 
were evaporated in a rotavapor (Buchi Labortechnik AG, Switzerland). Dry E-extracts 110 
(screening and Zippertex extractor) were resuspended in 0.5 mL of dimethyl sulfoxide 111 
(DMSO), and 1 mL of DMSO was necessary to resuspended the M-extracts. All 112 
samples were filtered through a DMSO-safe filter (0.22 µM; Tecknochroma).  113 
2.2.2 Large-scale extractions  114 
Following screening extraction assays, the tree whose leaf and stem extracts showed the 115 
highest antiproliferative activity was submitted to a scaled-up extract process using the 116 
accelerated solvent system, Zippertex extractor [9]. 25 g of stems and 40 g of leaves 117 
were extracted with dichloromethane (DCM) (2x100 mL), followed by MeOH (2x100 118 
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mL) at 100 bars. Afterwards, the solvents were evaporated and resuspended in DMSO 119 
at a concentration of 2 g dry weight (DW)/mL. 120 
2.2.3 Plant extract fractionation  121 
The MeOH extract from leaves was subjected to an additional fractionation procedure. 122 
Compounds of the extract were firstly separated by silica gel chromatography using a 123 
Combiflash-companion chromatograph (Serlabo) and ready-to-use RediSep column (40 124 
g), obtaining 8 fractions which were resuspended in DMSO, at a concentration of 0.4 g 125 
DW /mL. The mobile phase consisted of DCM (A) and MeOH (B) with the following 126 
increasing polarity gradient (t (min), %B): (5, 0), (7-17, 5), (18-28, 10), (32-42, 15), 127 
(44-55, 20) in 60 min at 30 mL/min.  128 
Flash chromatography was performed with two active fractions to purify the lead 129 
compounds. A Sunfire C18 III (10 x 250 mm) 5 µm column was used and the mobile 130 
phase consisted of water (A): acetonitrile (B), both added with 0.1% formic acid (v/v). 131 
A linear gradient of 100% A to 100% B was performed in 20 minutes with a flow of 30 132 
mL/min.  133 
 134 
2.3 MTT assay 135 
2.3.1 MTT cell assay conditions 136 
Cell viability was determined by the MTT assay [10]. The cell growth medium was 137 
removed and 0.63 mM of MTT and 18.4 mM of sodium succinate (from Sigma-Aldrich, 138 
Madrid, Spain) were added to 1 mL of fresh culture medium and the cells were 139 
incubated for 3 h at 37 ºC. Thereafter the medium was removed and formazan 140 
resuspended in DMSO supplemented with 0.57% CH3COOH and 10% sodium dodecyl 141 
sulfate (SDS) (from Sigma-Aldrich, Madrid, Spain). Absorbance was measured at 570 142 
nm in a UV2310 spectrophotometer (Dinko, Barcelona, Spain).   143 
2.3.2 Vehicle validation 144 
To determine the most suitable solvent and the appropriate volume to be used for the 145 
experiments DMSO and ethanol (EtOH) were analyzed at 0.01%, 0.02%, 0.1%, 0.2% 146 
and 1% (v/v) on HeLa cells. Cells were seeded at 3.4 x104 cells/well in 12 well plates 147 
and after 24 h of growth, DMSO or EtOH was added to the medium and the cell 148 
viability assay was carried out for 48 h.  149 
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2.3.3 Plant extract assays 150 
HeLa, HepG2 and MCF-7 cells were seeded at a density of 3.4x104 cells/well. Twenty-151 
four hours later, different amounts of each plant extraction were added to the cell 152 
cultures: 15 mg DW/mL and 3.33 mg DW/mL obtained from E-extraction, 7.5 mg 153 
DW/mL and 1.66 mg DW/mL from M-extraction and 3.33 µg DW/mL from Zippertex 154 
extractor. For the different fractions obtained 3 mg DW/mL and 0.66 mg DW/mL were 155 
assayed. Cell viability was determined 48 h later. 156 
2.3.4 Taxol toxicity 157 
Taxol (ChromaDex, Irvine, CA, USA) was used as an antiproliferative control. The half 158 
maximal inhibitory concentration (IC50) of taxol was determined in HeLa cell line. To 159 
this end, taxol was diluted in DMSO at the following concentrations: 0.5 nM, 5 nM, 50 160 
nM, 500 nM and 1500 nM. 3.4x104 cells/well were seeded and grown for 24 h. Taxol 161 
solution was added to the medium to analyze cell viability 48 h later. 162 
2.3.5  (3R,5R)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-β-D-163 
glucopyranoside and quercetin-3-O-rhamnoside assay 164 
(3R,5R)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-β-D-glucopyranoside 165 
(named as DHHP) and quercetin-3-O-rhamnoside (QR) were dissolved in DMSO at 1 166 
mg/mL. Two concentrations (15 µg/ml and 7.5 µg/ml) were tested. 3.4x104 cells/well 167 
were seeded and grown for 24 h. Each compound was added to the culture in the 168 
exponential phase and the effect was measured 48 h later. 169 
 170 
2.4 Analytical procedures 171 
2.4.1 HPLC-MS conditions  172 
An Alliance Waters 2695 HPLC instrument (Waters) including autosample 717, with a 173 
pump 600 equipped with a photodiode array 2998 detector and an evaporative light-174 
scattering detector 2420 was used. The HPLC analytical column used was Sunfire C18 175 
III (4.6 x 150 mm) 3.5 µm operating at 0.7 ml/min.  The mobile phase was water (A) 176 
and acetonitrile (B), both containing 0.1% of formic acid. A linear gradient from 100% 177 
of A to 100% of B was performed in 50 minutes. HPLC was fitted to a simple 178 
quadrupole Waters-Micromass®ZQ 2000 mass spectrometer. All analyses were done 179 
using electrospray ionization (ESI) in positive and negative mode with the following 180 
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MS conditions: capillary voltage: 3.5 kV; cone voltage: 25 V (+), 45 V (-); extractor 181 
voltage: 1 V; source temperature: 110 °C; desolvatation temperature: 250 °C; RF Lens: 182 
0.1 V; desolvatation gas flow: 450 L/h; cone gas flow: 50 L/h; LM1/HM1 resolution: 183 
15; ion Energy: 0.5 keV and Multiplier: 600 V.  184 
2.4.2 Nuclear magnetic resonance  185 
1H spectra were recorded with a Brüker Avance-500 instrument operating at 500 MHz. 186 
Deuterated methanol (MeOD) was used as a solvent. The obtained 1H chromatograms 187 
for each compound were compared with the corresponding simulated chromatogram 188 
estimated by ChemNMR software.  189 
 190 
2.5 Statistical analysis 191 
All the conditions were run in triplicate in at least two independent experiments. The 192 
statistical analysis was performed with SPSS (version 22.0). To analyze the effect of 193 
each treatment on cell viability, ANOVA analysis was performed. p-values lower than 194 
0.05 (*) or 0.01 (**) were considered statistically significant. 195 
 196 
3. Results  197 
3.1 Effects of C. avellana extracts on the viability human cancer cell lines  198 
The effects of different concentrations of DMSO or EtOH on the viability of HeLa cells 199 
were determined. In all conditions assayed, EtOH promoted a significant decrease in 200 
cell viability compared with non-treated cells (p<0.05; Figure 1). EtOH solutions 201 
presented more cytotoxicity than DMSO at all the concentrations tested, while DMSO 202 
treatment did not affect significantly the cell viability. Thus, DMSO was selected as the 203 
solvent for subsequent experiments at concentrations up to 1 % (v/v).  204 
As a control for cytotoxicity, HeLa cells were incubated in the presence of taxol. At the 205 
concentrations tested, viability of HeLa cells showed a dose-response effect: the amount 206 
of taxol added to the culture medium correlated with cytotoxicity. IC50 for taxol was 5 207 
nM in HeLa cells non-treated cells or cells in presence of DMSO as control (Figure 2). 208 
Thereafter, screening experiments using leaf and stem extracts obtained from three 209 
different C. avellana trees were carried out. To this end, dry extracts were resuspended 210 
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in DMSO, at a concentration of 2 g DW/mL in the case of E-extraction and 1 g DW/mL 211 
when the M-extraction procedure was followed. Twenty-four hours after seeding, HeLa, 212 
HepG2 and MCF-7 cells were incubated for 48 h in the presence of leaf and stem E- and 213 
M-extracts. HeLa cells treated with 15 mg DW/mL of E-extractions (Figure 3A) and 7.5 214 
mg DW/mL of M-extractions (Figure 3B) showed a strong reduction of cell viability 215 
compared to DMSO- and non-treated cells. Leaf and stem E- and M-extracts from trees 216 
II and III reduced viability of HeLa cells more extensively than extracts from tree I. The 217 
leaf M-extract from tree III was chosen to carry out a dose-response assay. The results 218 
showed that when the M-extract concentration added to the cell culture was increased 219 
(1.66, 3.75 and 7.50 mg DW/mL), the HeLa cell viability decreased (12.5, 2.4 and 1.9 220 
%, respectively).  221 
In HepG2 and MCF-7 cells, 3.33 mg DW/mL of leaf and stem E-extracts (Figures 3C 222 
and 2E) and 1.66 mg DW/mL of leaf and stem M-extracts (Figures 3D and 3F) were 223 
assayed. E- and M-extracts of trees II and III similarly reduced HepG2 cell viability and 224 
exhibited more cytotoxic effects than extracts obtained from tree I. Compared to 225 
HepG2, MCF-7 cells were more resistant to cytotoxic effects of C. avellana leaf and 226 
stem extracts. However, leaf and stem extracts from tree III reduced cell viability to a 227 
greater extent than trees I and II. 228 
Since leaf and stem extracts from tree III reduced cell viability more than trees I and II 229 
in the three tumour-derived cell lines, tree III was used for subsequent studies. 230 
Concerning the type of extraction, M-extraction showed a significantly higher viability-231 
reducing effect than E-extraction (p<0.01). 232 
 233 
3.2 Identification of C. avellana compounds with cell viability-reducing activity 234 
To identify compounds responsible for the growth inhibitory activity of C. avellana 235 
leaves and stems from tree III, a scaled up maceration-like extraction process was used, 236 
using Zippertex technology and two different solvents, MeOH and DCM. The 237 
anticancer activity of the resulting extracts was confirmed by assaying the viability of 238 
HeLa, HepG2 and MCF-7 cell lines (Figure 4). For stem extracts, no differences in 239 
viability were found for the three cell lines related to the solvent used for the extraction 240 
process (MeOH or DCM). However, MeOH leaf extracts showed a marked higher 241 
toxicity than DCM in all cell lines. Irrespective of the extraction solvent, the cell growth 242 
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inhibitory effect of leaf and stem extracts was similar for HeLa and HepG2 cells, while 243 
MCF-7 exhibited greater viability. Compared to control cells, MeOH leaf extracts 244 
significantly decreased HeLa, HepG2 and MCF-7 viability by 86, 89 and 71 %, 245 
respectively. 246 
Flash chromatography was used to fractionate the MeOH leaf extracts obtained using a 247 
Zippertex extractor. The cell viability-reducing activity of eight different fractions (3 248 
mg DW/mL and 0.66 mg DW/mL) were assayed in HeLa cells (Figure 5). Fractions 1, 249 
2, 6 and 7 showed a significantly reduced cell viability at both concentrations assayed. 250 
While fractions 1 and 2 promoted a dramatic reduction in cell viability, the effects of 251 
fractions 6 and 7 were dose-dependent at the concentrations assayed. Fractions 3, 4, 5 252 
and 8 showed only a statistically significant cell growth decrease at the higher 253 
concentration assayed (3 mg DW/mL). 254 
Fractions 6 and 7 were selected for further assays due to both their antiproliferative and 255 
dose-response activity. The chromatograms obtained by HPLC-MS for fractions 6 (A) 256 
and 7 (B) are presented in Figure 6. Spectra showed two masses, m/z 478 and m/z 448, 257 
present in both fractions 6 and 7. ESI in negative mode and MS allowed us to determine 258 
that the two masses corresponded to DHHP (C) and QR (D). 259 
 260 
3.3 Effects of DHHP and QR on the viability of human cancer cell lines 261 
HeLa, HepG2 and MCF-7 cells were incubated for 48 h in the presence of 7.5 µg/mL of 262 
DHHP or QR to assay the effect of both compounds on cell viability (Figure 7). DHHP 263 
and QR significantly decreased HeLa and HepG2 cell viability to similar levels: 51-40 264 
% for DHHP and 31-20 % for QR respectively. However, MCF-7 cell viability was 265 
hardly affected by any of the two compounds at the concentrations tested. Albeit not 266 
significant, a slightly reducing trend of MCF-7 cell viability was observed when using 267 
DHHP (8 %) and QR (2 %). 268 
 269 
4. Discussion  270 
Several studies have reported the content of growth inhibitory products, taxol and 271 
taxanes, in C. avellana cell cultures [3,7,11] and trace amounts of taxol in C. avellana 272 
tree extracts [4]. The C. avellana tree extracts used in this work showed trace amounts 273 
of taxol (data not shown). In the present study, identification of other compounds with 274 
anticancer activity in C. avellana tree extracts was addressed by assaying viability-275 
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reducing activity in different tumour-derived cell lines. For testing the effect of C. 276 
avellana extracts and isolated compounds on the viability of HeLa, HepG2 and MCF-7 277 
cell lines, first we confirmed that DMSO was a suitable vehicle for our studies. DMSO 278 
is an amphipathic molecule that is extensively used as a solvent for drug testing [12]. At 279 
a concentration of 1 % (v/v), DMSO did not promote changes in cell viability in any of 280 
the cell lines assayed. 281 
As a control to identify other compounds in C. avellana leaf and stem extracts with 282 
anticancer activity, we used taxol, a compound with anticancer activity in numerous 283 
tumour-derived cell lines. The IC50 value of taxol in HeLa cells was 5 nM, which is 284 
consistent with previously reported IC50 values for this compound in this cell line [13]. 285 
It is well known that secondary metabolite production and accumulation is dramatically 286 
affected by the season, plant variety and other environmental conditions [14]. To avoid 287 
seasonal variations, stems and leaves from C. avellana were collected in the same 288 
month (October) from three different locations in Catalonia. Two extraction approaches 289 
were applied: taxane (E-) and maceration (M-) extraction methods. The taxane 290 
extraction method (E-extraction) was used due to the fact that previous results of our 291 
group indicate its suitability for isolating active compounds from stems [8]. 292 
Furthermore, taxol and related taxanes were previously found in C. avellana. In 293 
addition, we used maceration with the aim of extracting a wider range of active 294 
compounds. In fact, we found that the M-extraction procedure was more suitable for 295 
leaves. 296 
The cell viability assays using leaf and stem extracts revealed that maceration was a 297 
better procedure than taxane extraction. Therefore, we used a large-scale maceration 298 
system using a Zippertex extractor. This extraction method allows isolation of enough 299 
quantity of compounds, reducing time and costs [9], and offered us an optimal 300 
procedure to obtain high yields of the compounds produced or accumulated in C. 301 
avellana. The growth inhibitory effects of leaf and stem Zippertex extracts was 302 
comparable to that observed during the screening experiments. Leaf extracts using 303 
MeOH as solvent produced the greater reduction of viability in the three cell lines 304 
assayed (reduced viability by 86, 89 and 71 % in HeLa, HepG2 and MCF-7 305 
respectively). This is consistent with the fact that leaves accumulate a great variety of 306 
secondary metabolites and MeOH is a very efficient universal solvent.  307 
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Identification of compounds with cell viability-reducing activity was conducted after 308 
silica gel chromatography fractionation of MeOH leaf extracts. The fractions that 309 
significantly reduced cell viability of HeLa cells in a dose-dependent manner were 310 
selected for subsequent analysis. The main compounds found in the selected fractions 311 
were two polyphenols: quercetin-3-O-rhamnoside, a flavonoid also named quercitrin 312 
(QR), and (3R,5R)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-ß-D-313 
glucopyranoside, a diarylheptanoid (DHHP).  314 
Polyphenols, a large group of ubiquitous and abundant natural compounds, present low 315 
toxicity, high structural diversity and exert a wide range of biological activities. 316 
Quercitrin is the rhamnose C-3 glycosylate form of quercetin, a flavonoid widely 317 
produced by a huge number of plants. Quercitin can be found in different glycoside 318 
forms and exhibits potential anticancer activity [15, 16]. High rates of quercitrin in C. 319 
avellana leaves (3235.5 mg/Kg DW) have been reported using a flavonoid-extraction 320 
methodology [17]. Several studies reported a significant role of flavonoids in growth 321 
inhibition of breast, colon, gastric, prostate, ovary, endometrium, and lung tumour-322 
derived cell lines [15, 18, 19]. 323 
As a diarylheptanoid, DHHP contains two aromatic rings linked by a seven-carbon 324 
aliphatic chain. This type of metabolite is mainly found in species from the Betulaceae, 325 
Zingiberaceae, Leguminoseae and Taccaceae families. The potential activity of these 326 
compounds has been described as antinflammatory, antioxidant, antitumor, estrogenic, 327 
hepatoprotective and neuroprotective [20, 21, 22]. Specifically, (3R,5R)-3,5-dihydroxy-328 
1,7-bis(4- hydroxyphenyl) heptanes 3-O-ß-D-glucopyranoside has been described by 329 
Yokosuka [23] in Tacca chantrieri, Quang [24] in Tacca plantaginea, and Riethmüller 330 
[25] in C. avellana. At a concentration of 21 nM, no cytotoxic activity of this compound 331 
was found in HL-60 cells (human promyelocytic leukemia cells), while an IC50 of 384 332 
and 445 nM was reported for HSC-2 (oral squamous cell carcinoma) and HGF (normal 333 
human gingival fibroblast) cells, respectively [23]. Moreover, Quang [24] reported that 334 
(3R,5R)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl) heptanes 3-O-ß-D-glucopyranoside 335 
inhibits tumor necrosis factor alpha (TNF-α)-induced nuclear factor kappa-B (NF-кβ) 336 
transcriptional activity and activates the transcriptional activity of peroxisome 337 
proliferator-activated receptors (PPARs), both in a dose-dependent manner in the 338 
HepG2 cell line, suggesting diarylheptanoids as a new target for the prevention and 339 
treatment of metabolic and inflammatory diseases. 340 
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Our results suggest that the presence of DHHP and QR in C. avellana confers a marked 341 
cell viability-reducing activity of leaf extracts from this tree. Although the 342 
chromatographic fractions analyzed by HPLC-MS did not present traces of taxol, we 343 
cannot rule out the presence of taxol or other compounds with anticancer activity in 344 
other non-analyzed fractions. Indeed, the presence of very low quantities of taxanes in 345 
C. avellana has been reported [3, 6, 7, 26]. 346 
Notably, the growth inhibitory effects of DHHP and QR depended on the cell line 347 
analyzed. At the concentrations assayed, both compounds reduced viability of HeLa and 348 
HepG2 cells more intensively than that of MCF-7 cells, which suggests the potential use 349 
of DHHP and QR as part of a multi-drug therapy against specific tumours, such as in 350 
the treatment of cervical cancer and liver carcinoma. Both bioactive compounds have 351 
been reported as pro-apoptotic when added to the cultured cancer cell lines [27, 28]. It is 352 
well known that multi-drug therapies improve the effectiveness of treatment in many 353 
diseases. In this regard, combinations of polyphenols with commercial drugs have been 354 
reported [29, 30, 31, 32, 33]. 355 
 356 
5. Conclusion 357 
In conclusion, this is the first report showing anticancer activity of C. avellana tree 358 
extracts against human cancer cell lines. In addition, we identified (3R,5R)-3,5-359 
dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-ß-D-glucopyranoside and quercetrin 360 
as contributors to the strong cell viability-reducing activity of C. avellana leaf extracts. 361 
Our findings open new insights into the anticancer activity of C. avellana in human 362 
cancer cell lines and highlight greater sensitivity of HeLa and HepG2 cells to the 363 
isolated compounds from C. avellana leaf extracts. Further research is needed to 364 
analyze the interaction among active substances present in C. avellana extracts and 365 
study their effect on primary cultures of cancer cells in in vivo assays, with the ultimate 366 
aim of developing new and more effective cancer therapies. 367 
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 482 
Figure legends 483 
Figure 1. Effect of DMSO and EtOH on cell viability of HeLa cells. Viability of HeLa 484 
cells was assayed 48 h after treatment with DMSO or EtOH at concentrations ranging 485 
from 0 (NT) to 1%. The results are presented as mean values ± SD from a representative 486 
experiment run in triplicate. NT: non-treated cells; DMSO: cells incubated in the 487 
presence of DMSO; EtOH: cells incubated in the presence of EtOH.  488 
 489 
Figure 2. Effect of taxol on cell viability of HeLa cells. Viability of HeLa cells was 490 
assayed 48 h after treatment with taxol at concentrations ranging from 0 (NT and DMSO) 491 
to 1500 nM. Each bar represents the mean ± SD of a representative experiment run in 492 
triplicate. Statistically significant differences between treatments and DMSO-treated cells 493 
(control) is presented as *p<0.05 and **p<0.01. NT: non-treated cells; DMSO: cells 494 
incubated in the presence of 1% DMSO. 495 
 496 
Figure 3. Cell growth inhibitory effects of extracts prepared from leaves or stems of 497 
three different C. avellana trees (I, II, III) by taxane extraction (E) or maceration 498 
extraction (M). Viability was assayed in HeLa cells after 48 h of treatment with 15 mg 499 
DW/mL for E-extracts (A) and 7.5 mg DW/mL for M-extracts (B), and HepG2 and 500 
MCF-7 cells 48 h following treatment with 3.33 mg DW/mL for E-extracts (C, E) and 501 
1.66 mg DW/mL for M-extracts (D, F), using 1% DMSO as a solvent. The results are 502 
17 
 
expressed as % (mean ± SD of a representative experiment run in triplicate) of the values 503 
found in non-treated cells. NT: non-treated cells; DMSO: cells incubated in the presence 504 
of 1% DMSO; T: cells treated with 5 nM taxol.  505 
 506 
Figure 4.  Cell growth inhibitory activity of Zippertex extracts from C. avellana stems 507 
and leaves on HeLa, HepG2 and MCF-7 cell lines. Viability of all cell lines was assayed 508 
48 h after no treatment in absence (NT) or presence of 1% DMSO (DMSO) and treatment 509 
with 5nM taxol (T), DCM or MeOH Zippertex extracts from stems and leaves, using 1% 510 
DMSO as a solvent. The results are presented as mean values ± SD from a representative 511 
experiment run in triplicate. Statistically significant differences compared to the 512 
respective control (DMSO) are presented as *p<0.05; **p<0.01.  513 
	514 
Figure 5. Effect of eight chromatographic fractions obtained from MeOH C. avellana 515 
leaf extracts on viability of HeLa cells. Viability was assayed in HeLa cells after 48 h of 516 
no treatment in absence (NT) or presence of 1% DMSO (DMSO) and treatment with 0.66 517 
and 3 mg dry weight /mL, using 1% DMSO as a solvent. The results presented are mean 518 
values ± SD from a representative experiment run in triplicate. Statistically significant 519 
differences compared to controls (DMSO) are presented as *p<0.05; **p<0.01.  520 
	521 
Figure 6. HPLC-MS profile of fraction 6 (A) and fraction 7 (B) of MeOH C. avellana 522 
leaf extracts obtained with a Zippertex extractor. MS chromatograms (ESI-) of compound 523 
3: DHHP (C) and 4: QR (D) are shown.  524 
	525 
Figure 7. Cell growth inhibitory activity of quercetin-3-O-rhamnosid (QR) and (3R,5R)-526 
3,5-dihydroxy-1,7-bis(4-hydroxyphenyl) heptane 3-O-β-D-glucopyranoside (DHHP) on 527 
HeLa, HepG2 and MCF-7 cells. Viability was assayed in all cell lines after 48 h of no 528 
treatment in absence (NT) or presence of 1% DMSO (DMSO) and treatment with 7.5 529 
mg/mL QR or DHHP, using 1% DMSO as a solvent. The results are presented as mean 530 
values ± SD from a representative experiment run in triplicate. Statistically significant 531 
differences compared to the corresponding control (DMSO) are presented as *p<0.05; 532 
**p<0.01.  533 






